May 09, 2025 • Benzinga
SOMEWHAT-BULLISH
New FDA Leadership Could Raise The Bar For Drug Approvals
New FDA Leadership Team: The FDA's top leadership has shifted under Commissioner Dr. Marty Makary, with Dr. Vinayak "Vinay" Prasad now heading the Center for Biologics Evaluation and Research ( CBER ) and Dr. Sanjula Jain-Nagpal serving as Associate Director of Policy & Research Strategy in the ...
May 09, 2025 • Benzinga
NEUTRAL
Generic Drugs Market size is projected to reach USD 594.99 billion by 2031, With growing at a CAGR of 5.0% | The Insight Partners
US & Canada, May 09, 2025 ( GLOBE NEWSWIRE ) -- According to a new comprehensive report from The Insight Partners, the global Generic Drugs Market is growing owing to patent expiry and loss of market exclusivity, along with increasing government initiatives to promote the use of generic drugs.
May 09, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Pfizer ( PFE ) Just Overtook the 20-Day Moving Average
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
May 09, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
5 Low Price-to-Sales Stocks That Deserve a Place in Your Portfolio
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like PCB, GIII, ROCK, PFE and PAM hold promise.
May 08, 2025 • GlobeNewswire
SOMEWHAT-BULLISH
Serina Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights
HUNTSVILLE, May 08, 2025 ( GLOBE NEWSWIRE ) -- Serina Therapeutics, Inc. ( "Serina" ) ( NYSE American: SER ) , a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, today reported its financial results for the first quarter ended March 31, ...
May 08, 2025 • Benzinga
NEUTRAL
Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks 3 Pharma ETFs To Watch As Trump Turns Up The Heat On Drugmakers - AstraZeneca ( NASDAQ:AZN ) , iShares U.S. Pharmaceutical ETF ( ARCA:IHE )
Trump's push to tie Medicaid drug prices to lower international benchmarks could erase $1 trillion in revenues over 10 years. Don't miss this list of 10 overlooked stocks-including one paying a 9% dividend-before Wall Street catches on.